Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden
Skin melanoma cells are tightly interconnected with their tumor microenvironment (TME), which influences their initiation, progression, and sensitivity/resistance to therapeutic interventions. An immune-active TME favors patient response to immune checkpoint inhibition (ICI), but not all patients re...
Main Authors: | George Georgoulias, Apostolos Zaravinos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1006665/full |
Similar Items
-
Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
by: Paraskevi Vryza, et al.
Published: (2023-12-01) -
The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
by: Camille Moeckel, et al.
Published: (2023-04-01) -
Editorial: Mutational signatures and immune response in cancer
by: Ilias Georgakopoulos-Soares, et al.
Published: (2023-05-01) -
Integration of the Tumor Mutational Burden and Tumor Heterogeneity Identify an Immunological Subtype of Melanoma With Favorable Survival
by: Yanmei Gao, et al.
Published: (2020-10-01) -
The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
by: Shengjin Cui, et al.
Published: (2023-02-01)